BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast
,
Laser capture microdissection
,
Doxycycline
,
rs2476601
,
LEP
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptors neurotensin
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Neurotensin and Neurotensin Receptors in Stress-related Disorders: Pathophysiology & Novel Drug Targ…
Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radioph…
Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, …
Neurotensin counteracts hair growth inhibition induced by chronic restraint stress.
Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcino…
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With…
Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial …
Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.
Regulation of Fat-stimulated Neurotensin Secretion in Healthy Subjects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ